Current Diagnosis and Treatment of Irritable Bowel Syndrome
), Muhammad Firhat Idrus(2),
(1) Faculty of Medicine, Universitas Indonesia
(2) Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital
Corresponding Author
Abstract
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, and altered bowel habits, often without any identifiable organic cause. The diagnosis of IBS typically involves a thorough clinical evaluation, including a detailed patient history and symptom assessment, often guided by the Rome IV criteria. Laboratory tests and imaging studies are generally employed to rule out other conditions. Current treatment strategies for IBS are multifaceted, aiming to alleviate symptoms and improve quality of life. They include dietary modifications, pharmacological treatment for symptoms management, and psychological interventions. Emerging therapies, such as microbiome modulation and novel pharmacologic agents, are under investigation and hold promise for future management of IBS. Overall, an individualized approach to treatment, considering both physiological and psychological factors, is essential for optimal patient outcomes.
Keywords: Irritable bowel syndrome, diagnosis, treatment
Keywords
References
Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17–44.
Wilkins Prof. T, Pepitone C, Alex B, Schade RR. Diagnosis and management of IBS in adults. Am Fam Physician. 2012;86(5):419–26.
Fauzi A, Makmun D, Maulahela H, Pribadi
R. Konsensus Nasional Penatalaksanaan Irritable Bowel Syndrome dan Dispepsia Fungsional. Perkumpulan Gastroenterologi Indonesia; 2021.
Oka P, Parr H, Barberio B, Black CJ, Savarino E V., Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol [Internet]. 2020;5(10):908–17. Available from: http://dx.doi.org/10.1016/S2468- 1253(20)30217-X
Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol [Internet]. 2016;1(2):133–46. Available from: http://dx.doi.org/10.1016/S2468- 1253(16)30023-1
Mayer EA, Ryu HJ, Bhatt RR. The neurobiology of irritable bowel syndrome. Mol Psychiatry. 2023;28(4):1451–65.
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214–40.
Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil. 2016;22(4):558–74.
Agrawal A, Houghton LA, Reilly B, Morris J, Whorwell PJ. Bloating and distension in irritable bowel syndrome: The role of gastrointestinal transit. Am J Gastroenterol. 2009;104(8):1998–2004.
Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol [Internet].
;56(3):193–217. Available from: https://doi.org/10.1007/s00535-020-01746- z
Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26(SUPPL. 3):119–21.
Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65(8):1279–88.
Xu D, Gao J, Gillilland M, Wu X, Song I, Kao JY, et al. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology [Internet]. 2014;146(2):1–13. Available from: http://dx.doi.org/10.1053/j.gastro.2013.10.0 26
Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;152(5):1042- 1054.e1.
Turcotte JF, Kao D, Mah SJ, Claggett B, Saltzman JR, Fedorak RN, et al. Breaks in the wall: Increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Gastrointest Endosc [Internet]. 2013;77(4):624–30. Available from: http://dx.doi.org/10.1016/j.gie.2012.11.006
Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, et al. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil. 2019;31(12):1–8.
El-Salhy M. Diet in the pathophysiology and management of irritable bowel syndrome. Cleve Clin J Med. 2016;83(9):663–4.
Kesuma Y, Sekartini R, Timan IS, Kurniawan A, Bardosono S, Firmansyah A, et al. Irritable bowel syndrome in Indonesian adolescents. J Pediatr (Rio J) [Internet]. 2021;97(2):197–203. Available from: https://doi.org/10.1016/j.jped.2020.02.001
Camilleri M, Ford AC. Pharmacotherapy for irritable bowel syndrome. J Clin Med. 2017;6(11):1–16.
Ford AC, Moayyedi P, Chey WD, Harris
LA, Lacy BE, Saito YA, et al. American college of gastroenterology monograph on management of irritable bowel syndrome. Am J Gastroenterol [Internet].
;113(S2):1–18. Available from: http://dx.doi.org/10.1038/s41395-018- 0084-x
Jung H-K, Song KH, Kim HJ, Koo HS, Kwon YH, Shin HD, et al. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil [Internet]. 2018;24(2):197–215. Available from: www.jnmjournal.org
Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta- Analysis. Am J Gastroenterol [Internet]. 2019;114(1):21–39. Available from: http://dx.doi.org/10.1038/s41395-018- 0222-5
Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, et al. The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019;19(1):1–10.
Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EMM, Moayyedi P, et al. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020;69(1):74–82.
Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044–60.
Akbar A, Yiangou Y, Facer P, Walters JRF, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57(7):923–9.
Magge S, Lembo A. Low-FODMAP diet for treatment of irritable bowel syndrome. Gastroenterol Hepatol. 2012;8(11):739–45.
Article Metrics
Abstract View
: 74 times
Download : 72 times
DOI: 10.24871/261202576-83
Refbacks
- There are currently no refbacks.
